Maximizing CAR-T cell yields: scalable solutions with perfusion and stirred-tank bioreactors

J Hengst, Q Rafiq, R Ladi et al

27 February 2025

Innovator Insight

Achieving robust and scalable AAV empty/full capsid separation for gene therapy

Julio Huato, Mark Schofield

26 February 2025

Innovator Insight

Next-generation risk mitigation in the temperature-controlled supply chain for advanced therapies with ISO 21973 compliance

Edward Grimley, Leanne Kodsmann

04 December 2024

Innovator Insight

Navigating the opportunities and challenges in analytical development of flowcytometry for T cell therapy

Therese Choquette, Minh Ngoc Duong

25 November 2024

Innovator Insight

Extracellular vesicles: setting your path to IND with advanced characterization packages

Davide Zocco

28 October 2024

Innovator Insight

Control your AAV titers with in-line UV-Vis analysis and PAT-driven UF/DF systems

Brandon Goldberg

10 October 2024

Innovator Insight

How will process development and analytical innovation drive growth for the future of cell and gene therapies?

Mark Santos

07 October 2024

Innovator Insight

Precision in production: optimizing monitoring and quality control for high-value plasmids

Oleksandr Karpenko

02 October 2024

Innovator Insight

Quantitative analysis of lipids and nucleic acids in lipid nanoparticles using monolithic column

N Pavlin, M Bavčar, T Kovačič et al

29 July 2024

Innovator Insight

Overcoming challenges in gene therapy analytics

Anthony J Blaszczyk, Ana Carreras González

25 July 2024

Innovator Insight

Advancing AAV production with high-throughput screening and transcriptomics

Christopher A Reid, Markus Hörer, Mohammad A Mandegar

23 July 2024

Innovator Insight

Alternative solutions to separate AAV full and empty capsids using anion exchange

Åsa Hagner-McWhirter, Mark Schofield

24 June 2024

Innovator Insight

Analytical strategies for sterility and mycoplasma testing in biotherapies: from early development to production scale-up

Sharon Rouw, Michael Brewer

17 June 2024

Innovator Insight

G-Rex bioreactors incubated in Heracell™ Vios™ CR CO2 Incubators help prevent cross contamination and bacterial contamination in cell and gene modified cell therapy production

M Kay Bates, D Fick, J Schneider et al

12 June 2024

Innovator Insight

Accelerating AAV process development with a PAT-driven TFF system

Teva Smith

21 May 2024

Innovator Insight

Accelerating cell therapy production: realizing the advantages of rapid analytical testing solutions

Seth Peterson

07 May 2024

Innovator Insight

Simplifying residual DNA quantitation and biotherapeutic manufacturing

Ilaria Scarfone

13 December 2023

Innovator Insight

AAV & lentiviral vector titer determination: past, present, & future

Mark White, John Bechill, Peng Wang

01 November 2023

Innovator Insight

mRNA fragmentation and quality assessment using ion pair reverse-phase analytics

A Ferjančič Budihna, A Martinčič Celjar, S Lebar et al

01 November 2023

Innovator Insight

Exploring & overcoming the challenges of cell & gene-modified cell therapy CMC

Karen Doucette, Julia Sable, Larry Bellot

18 October 2023

Innovator Insight

High-throughput process & analytical platforms to accelerate gene therapy scale-up

Patrick Starremans, Kenneth Warrington, Nithya Jesuraj

28 September 2023

Innovator Insight